Bangma CH - Search Results

1

Relationship Between Baseline Prostate-specific Antigen on Cancer Detection and Prostate Cancer Death: Long-term Follow-up from the European Randomized Study of Screening for Prostate Cancer.

Remmers S, Bangma CH, Godtman RA, Carlsson SV, Auvinen A, Tammela TLJ, Denis LJ, Nelen V, Villers A, Rebillard X, Kwiatkowski M, Recker F, Wyler S, Zappa M, Puliti D, Gorini G, Paez A, Lujan M, Nieboer D, Schröder FH, Roobol MJ. Remmers S, et al. Among authors: bangma ch. Eur Urol. 2023 Nov;84(5):503-509. doi: 10.1016/j.eururo.2023.03.031. Epub 2023 Apr 21. Eur Urol. 2023. PMID: 37088597 Free PMC article. Clinical Trial.

2

Prostate specific antigen in a community-based sample of men without prostate cancer: correlations with prostate volume, age, body mass index, and symptoms of prostatism.

Bosch JL, Hop WC, Bangma CH, Kirkels WJ, Schröder FH. Bosch JL, et al. Among authors: bangma ch. Prostate. 1995 Nov;27(5):241-9. doi: 10.1002/pros.2990270503. Prostate. 1995. PMID: 7479391 Free article. Clinical Trial.

3

Re: Automated prostate volume determination with ultrasonographic imaging.

Bangma CH, Schröder FH. Bangma CH, et al. J Urol. 1996 Jan;155(1):292-3. doi: 10.1016/s0022-5347(01)66630-8. J Urol. 1996. PMID: 7490864 Free article. No abstract available.

4

The value of screening tests in the detection of prostate cancer. Part I: Results of a retrospective evaluation of 1726 men.

Bangma CH, Kranse R, Blijenberg BG, Schröder FH. Bangma CH, et al. Urology. 1995 Dec;46(6):773-8. doi: 10.1016/S0090-4295(99)80342-2. Urology. 1995. PMID: 7502414

5

The value of screening tests in the detection of prostate cancer. Part II: Retrospective analysis of free/total prostate-specific analysis ratio, age-specific reference ranges, and PSA density.

Bangma CH, Kranse R, Blijenberg BG, Schröder FH. Bangma CH, et al. Urology. 1995 Dec;46(6):779-84. doi: 10.1016/S0090-4295(99)80343-4. Urology. 1995. PMID: 7502415

6

[Variability of values of prostate-specific antigen determined with 6 methods].

Bangma CH, Blijenberg BG, Schröder FH. Bangma CH, et al. Ned Tijdschr Geneeskd. 1994 Apr 16;138(16):813-7. Ned Tijdschr Geneeskd. 1994. PMID: 7514278 Dutch.

7

Parameters of prostate volume and shape in a community based population of men 55 to 74 years old.

Bosch JL, Hop WC, Niemer AQ, Bangma CH, Kirkels WJ, Schröder FH. Bosch JL, et al. Among authors: bangma ch. J Urol. 1994 Nov;152(5 Pt 1):1501-5. doi: 10.1016/s0022-5347(17)32456-4. J Urol. 1994. PMID: 7523706

8

Volume adjustment for intermediate prostate-specific antigen values in a screening population.

Bangma CH, Grobbee DE, Schröder FH. Bangma CH, et al. Eur J Cancer. 1995;31A(1):12-4. doi: 10.1016/0959-8049(94)00309-s. Eur J Cancer. 1995. PMID: 7535074

9

Prostate-specific antigen: its clinical use and application in screening for prostate cancer.

Bangma CH, Blijenberg BG, Schröder FH. Bangma CH, et al. Scand J Clin Lab Invest Suppl. 1995;221:35-44. doi: 10.3109/00365519509090562. Scand J Clin Lab Invest Suppl. 1995. PMID: 7544483 Review.

10

Serial prostate specific antigen measurements and progression in untreated confined (stages T0 to 3NxM0, grades 1 to 3) carcinoma of the prostate.

Bangma CH, HOP WCJ, Schröder FH. Bangma CH, et al. J Urol. 1995 Oct;154(4):1403-6. J Urol. 1995. PMID: 7544841

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

352 results

Search Page

Filters